Anne‐Claire Gac

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Olivier Casasnovas, Réda Bouabdallah, Pauline Brice et al. · The Lancet Oncology · 2019 · 201 citations · Full text

Pet-adapted Treatment, Lymphoid Neoplasia, Medicine +5

Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy

Nicolas Aide, Christophe Fruchart, Catherine Nganoa et al. · European Radiology · 2020 · 88 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +8

Agricultural pesticide exposure and the molecular connection to lymphomagenesis

Julie Agopian, Jean‐Marc Navarro, Anne‐Claire Gac et al. · The Journal of Experimental Medicine · 2009 · 87 citations · Full text

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc‐Matthieu Fornecker, Julien Lazarovici, Igor Aurer et al. · Journal of Clinical Oncology · 2022 · 65 citations · Full text

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Jordan Gauthier, Xavier Poiré, Anne‐Claire Gac et al. · Bone Marrow Transplantation · 2018 · 43 citations · Full text

Transplantation, Marrow Transplantation, Medicine +10